WisdomTree 7-10 Year Laddered Treasury Fund (NASDAQ:USIN – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 193 shares, a decrease of 98.7% from the September 30th total of 15,000 shares. Based on an average daily volume of 1,874 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.2% of the company’s shares are sold short.
Institutional Investors Weigh In On WisdomTree 7-10 Year Laddered Treasury Fund
An institutional investor recently bought a new stake in WisdomTree 7-10 Year Laddered Treasury Fund stock. Kestra Advisory Services LLC acquired a new stake in WisdomTree 7-10 Year Laddered Treasury Fund (NASDAQ:USIN – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 16,104 shares of the company’s stock, valued at approximately $807,000. Kestra Advisory Services LLC owned about 17.89% of WisdomTree 7-10 Year Laddered Treasury Fund as of its most recent SEC filing.
WisdomTree 7-10 Year Laddered Treasury Fund Price Performance
Shares of NASDAQ USIN opened at $47.93 on Tuesday. WisdomTree 7-10 Year Laddered Treasury Fund has a 1 year low of $46.66 and a 1 year high of $51.43. The firm has a 50-day simple moving average of $47.87 and a two-hundred day simple moving average of $49.44.
WisdomTree 7-10 Year Laddered Treasury Fund Company Profile
The WisdomTree 7-10 Year Laddered Treasury Fund (USIN) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an equally weighted index comprised of US Treasurys maturing between 7-10 years. USIN was launched on Mar 14, 2024 and is issued by WisdomTree.
Further Reading
- Five stocks we like better than WisdomTree 7-10 Year Laddered Treasury Fund
- A Solid Margin Story Means the Sell-Off in DECK May Be Overdone
- Verizon’s Q3 Results Show Why SpaceX’s Spectrum Grab Isn’t a Major Threat
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
Receive News & Ratings for WisdomTree 7-10 Year Laddered Treasury Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree 7-10 Year Laddered Treasury Fund and related companies with MarketBeat.com's FREE daily email newsletter.
